About 8 results found for searched term "Tenofovir" (0.209 seconds)
Cat.No. | Name | Target |
---|---|---|
M4958 | GS-7340 | HIV Protease |
Tenofovir alafenamide | ||
GS-7340(Tenofovir alafenamide) is a procompound of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate. | ||
M5051 | Tenofovir | Reverse Transcriptase |
GS 1278; PMPA; TDF | ||
Tenofovir is a nucleotide reverse transcriptase inhibitor used in studies related to HIV and chronic hepatitis B (HBV). | ||
M5052 | Tenofovir Disoproxil Fumarate | HIV Protease |
Tenofovir DF | ||
Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral compounds, it inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination. | ||
M6274 | Tenofovir Disoproxil | HIV Protease |
Bis(POC)-PMPA; GS 4331 | ||
Tenofovir dsoproxil is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B. | ||
M10364 | Tenofovir hydrate | HIV Protease |
GS 1278 hydrate; PMPA hydrate | ||
Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B. | ||
M20783 | Tenofovir alafenamide hemifumarate | Reverse Transcriptase |
TAF hemifumarate, GS-7340 hemifumarate | ||
Tenofovir alafenamide (TAF, GS-7340) hemifumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection. | ||
M20784 | Tenofovir alafenamide fumarate | Reverse Transcriptase |
TAF fumarate, GS-7340 fumarate | ||
Tenofovir alafenamide (TAF, GS-7340) fumarate is a precursor compound of Tenofovir and a novel nucleotide reverse transcriptase inhibitor for use in studies related to HIV-1 infection. | ||
M30871 | Tenofovir exalidex | HIV Protease |
CMX-157 | ||
Tenofovir exalidex (CMX157) is a lipid conjugate of the acyclic nucleotide analog Tenofovir with activity against both wild-type and antiretroviral drug-resistant HIV strains, including multidrug nucleoside/nucleotide analog-resistant viruses. Tenofovir exalidex is active against all major subtypes of HIV-1 and HIV-2 in fresh human PBMCs and against all HIV-1 strains evaluated in monocyte-derived macrophages, with EC50s ranging between 0.2 and 7.2 nM. CMX157 is orally available and has no apparent toxicity. Tenofovir exalidex also shows antiviral activity against HBV. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.